Melt analysis of mismatch amplification mutation assays (melt-MAMA): a functional study of a cost-effective SNP genotyping assay in bacterial models. by Birdsell, Dawn N. et al.
Melt Analysis of Mismatch Amplification Mutation Assays
(Melt-MAMA): A Functional Study of a Cost-Effective SNP
Genotyping Assay in Bacterial Models
Dawn N. Birdsell1, Talima Pearson1, Erin P. Price1, Heidie M. Hornstra1, Roxanne D. Nera1, Nathan
Stone1, Jeffrey Gruendike1, Emily L. Kaufman1, Amanda H. Pettus1, Audriana N. Hurbon1, Jordan L.
Buchhagen1, N. Jane Harms5, Gvantsa Chanturia2, Miklos Gyuranecz4, David M. Wagner1, Paul S.
Keim1,3*
1Center for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, Arizona, United States of America, 2National Center for Disease Control and Public
Health and Ilia State University, Tbilisi, Georgia, United States of America, 3 Translational Genomics Research Institute, Phoenix, Arizona, United States of America,
4 Veterinary Medical Research Institute, Hungarian Academy of Sciences, Budapest, Hungary, 5Department of Veterinary Pathology, Western College of Veterinary
Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Abstract
Single nucleotide polymorphisms (SNPs) are abundant in genomes of all species and biologically informative markers
extensively used across broad scientific disciplines. Newly identified SNP markers are publicly available at an ever-increasing
rate due to advancements in sequencing technologies. Efficient, cost-effective SNP genotyping methods to screen sample
populations are in great demand in well-equipped laboratories, but also in developing world situations. Dual Probe TaqMan
assays are robust but can be cost-prohibitive and require specialized equipment. The Mismatch Amplification Mutation Assay,
coupledwithmelt analysis (Melt-MAMA), is flexible, efficient and cost-effective. However, Melt-MAMA traditionally suffers from
high rates of assay design failures and knowledge gaps on assay robustness and sensitivity. In this study, we identified
strategies that improved the success of Melt-MAMA. We examined the performance of 185 Melt-MAMAs across eight different
pathogens using various optimization parameters. We evaluated the effects of genome size and %GC content on assay
development. When used collectively, specific strategies markedly improved the rate of successful assays at the first design
attempt from ,50% to ,80%. We observed that Melt-MAMA accurately genotypes across a broad DNA range (,100 ng to
,0.1 pg). Genomic size and %GC content influence the rate of successful assay design in an independent manner. Finally, we
demonstrated the versatility of these assays by the creation of a duplex Melt-MAMA real-time PCR (two SNPs) and conversion
to a size-based genotyping system, which uses agarose gel electrophoresis. Melt-MAMA is comparable to Dual Probe TaqMan
assays in terms of design success rate and accuracy. Although sensitivity is less robust than Dual Probe TaqMan assays, Melt-
MAMA is superior in terms of cost-effectiveness, speed of development and versatility. We detail the parameters most
important for the successful application of Melt-MAMA, which should prove useful to the wider scientific community.
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Introduction
Single nucleotide polymorphisms (SNPs) are point mutations
with biological significance across diverse scientific disciplines
ranging from medicine to agriculture. SNPs are useful in predicting
the disposition for some diseases [1,2], as indicators for the genetic
basis for varying responses to pharmacological drug treatment [3],
for classifying bacterial populations into specific genetic groups
[4,5], and for association with specific phenotypic traits, such as
insecticide resistance in insects [6]. Technologies that permit cost-
effective yet expeditious SNP interrogation are in demand.
Numerous SNP detection technologies have been developed
over the past 20 years and have been extensively described in
several published reviews [7–10]. Many of these technologies are
based on real-time PCR. Real-time PCR instruments are present in
many clinical and research laboratories because of their efficiency,
automation, experimental simplicity, and amenability to high
capacity throughput. Two of the more prevalent real-time
technologies for SNP interrogation on these instruments are Dual
Probe TaqMan and Allele-Specific (AS) PCR assays, each of which
utilizes different genotyping strategies and material components.
Dual Probe TaqMan assays amplify the target amplicon,
whereas the SNP locus is concurrently genotyped by one of the
two allele-specific internal probes. These internal probes are
differentially labeled with fluorescent dyes. For TaqMan assays,
the specificity of the probe to an internal region of the amplicon
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confers superb detection of extremely low template amounts down
to a single genomic equivalent [4,5]. However, the fluorescently
labeled internal probes make the cost of TaqMan assays
approximately fourteen times higher than the cost of assays that
are solely based on unlabeled primers, such as AS-PCR assays
(https://products.appliedbiosystems.com) (https://www.idtdna.
com). As a consequence, Dual Probe TaqMan assays are cost-
prohibitive for laboratories with a limited budget or in studies
interested only in small-scale SNP screening. In addition, the turn-
around time required to synthesize and ship labeled internal
probes takes approximately 7–10 days compared with only 2–
3 days for unlabeled primers. This slower production rate of
TaqMan probe assays may make them unfeasible in situations that
demand rapid confirmation of newly identified SNPs.
SNP genotyping with an AS-PCR assay is achieved by two AS-
forward primers that act in concert with a single reverse primer.
The AS primer design introduces a mismatch at the 39 end with a
DNA template composed of a non-complementary SNP state
(non-allelic template). This non-complementary base mismatch is
not observed with an allelic (matched) template. The 39 end
mismatch decreases the extension efficiency of Taq polymerase by
15% to 50% per cycle [11] resulting in lower PCR efficiency when
compared to the perfect primer/template complex [12]. When the
two AS-specific primers compete for the same template, the
perfect primer/template interaction out-competes the mismatch
primer/template interaction due to its more rapid extension
efficiency, causing this primer-template complex to dominate in
the PCR [13,14]. SNP genotyping in AS-PCR is further enhanced
by the incorporation of a destabilizing point mutation at the
penultimate (–2) or ante-penultimate (–3) base position of the
forward AS primers [15–18]. The labeling of one of the AS-
forward primer with a GC-clamp enables facile differentiation of
AS-PCR products through melt-curve analysis [17,19–21], which
has been termed mismatch amplification mutation assay or Melt-
MAMA [19,22]. Although AS-PCR assays are cost-effective due to
the exclusive use of unlabeled primers, it is a technology hampered
by high assay failure rates of,50% [23]. In addition, considerable
knowledge gaps in areas such as assay capacity, sensitivity, and
limitations exist.
There is a need for cost-effective genotyping alternatives for
which unlabeled primer technologies such as Melt-MAMA could
easily satisfy [16–20,22,24,25]. Thus, it is important to identify
design principles that reduce traditionally high assay failure rates.
A better understanding of the robustness and sensitivity of Melt-
MAMA would also promote its maximal application. In this study,
we present specific strategies that improved the success rate of first-
pass Melt-MAMA design, providing rates comparable to the Dual
Probe TaqMan assay. Although the information presented here is
based on bacterial pathogens, MAMA technologies have been
successfully applied to viruses [26,27] and eukaryotic species,
including humans [17,18,20]. Therefore, these guidelines can be
employed by the broader scientific community to maximize
successful application of the Melt-MAMA SNP genotyping
technology on other organisms of interest.
Results and Discussion
Molecular schemes for subtyping bacterial pathogens rely on
detecting known DNA-based differences among isolates, such as
SNPs. SNPs are the most common DNA difference found among
bacterial strains, yet assaying for them in a cost-effective and
reliable manner has been problematic. Here, we summarize our
efforts in employing Melt-MAMA across multiple pathogenic
bacterial species for SNP interrogation and the positive effects of
specific strategies that maximized the successful application of this
cost-effective technique. Several optimization strategies that, when
used collectively, effectively improved the assay success rate at the
first design attempt from ,50% to ,80%. In addition, we
demonstrated the Melt-MAMA generated amplification products
can be monitored with the even more cost-effective, although
slower, approach of agarose-gel electrophoresis. We conclude that
Melt-MAMA is a highly effective and robust SNP genotyping
approach applicable to laboratories with varying economic
resources.
Melt-MAMAs are robust across genetically diverse
genomes
Over the course of multiple studies, 185 SNPs from eight
bacterial pathogen species, differing greatly with respect to
sequence, genome size and %GC content (Table 1), were
developed into Melt-MAMA genotyping assays. All listed patho-
gens, with the exception of E. coli, are federally designated as Select
Agents because of their potential for bio weaponization. Informa-
tion gained from molecular assays that enable rapid SNP
genotyping is critical for forensic and public health investigative
efforts and could also be used to shape the course of therapeutic
treatments by monitoring the presence of mutations associated with
drug-resistance.
A ‘unique’ destabilizing mismatch mutation enhance
allele specificity
The SNP-allele discrimination of a MAMA is greatly enhanced
by the design of an additional mismatch engineered at the
penultimate or antepenultimate base position of the primer [15–
17] (Figure 1). This mismatch strategy generates primer-template
complexes containing a single- or double-base mismatch at the
39 end of the primer (Figure 2). This capitalizes on the principle
that primers with mismatch(es) at the 39-end tend to ‘‘destabilize’’
primer-template annealing at mismatched sites and, therefore, will
result in lower PCR efficiencies due to decreased extension
efficiency of Taq polymerase [12] (Figure 2). In principle, the
single mismatched primer-template complex is much more efficient
than the double mismatched complex and, consequently, this
efficiency differential permits the single mismatched primer to
dominant the PCR (Figure 2I & IV).
It is imperative that Melt-MAMAs retain the two-nucleotide
mismatch at the 39 end of the non-complementary AS-MAMA
primers after the initial cycle when the newly synthesized
‘‘nascent’’ DNA template becomes the dominant PCR template
(Figure 2Ic & IVc). This feature retains the efficiency differential
between the two competing AS-MAMA primers throughout the
PCR. We designed all of our AS-MAMA primers to have
destabilizing mismatch mutations with a nucleotide base that was
uniquely different between the primer pairs (Figure 1 & 2) and the
template DNA. Design consideration for the mismatch position
penultimate or antepenultimate (–2 or –3, respectively) for each
assay was based on achieving a unique nucleotide base at the
mismatch positions while avoiding secondary structures within/
among assay primers. We observed no advantage in assay function
based on whether the mismatch position is –2 or –3 from the 39-
end, as previously observed [28]. Our experiments have shown
that retaining this two-nucleotide mismatch strategy throughout
the entire PCR enhanced SNP discrimination by minimizing the
amplification via the non-complementary primer (data not shown).
Li et al. identified optimal two-nucleotide mismatch combina-
tions for all SNP polymorphic states based on non-competitive
TaqMan MAMA, where the AS-MAMA primers were separated
Function of a Cost-Effective SNP Genotyping Assay
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into two individual reactions [16]. A small subset of combinations
contained the same mutation at the mismatch positions for both
AS-MAMA primers, a logical strategy from studies based on non-
competitive MAMA [16]. However, these ideal combinations may
not hold true under actual assay conditions where both AS-
MAMA primers compete for the same DNA template, as in the
Melt-MAMA single tube format (Figure 1). In such competitive
assay conditions, the two-nucleotide mismatch advantage will be
lost if the destabilizing mutation is not different from the DNA
template and its alternate AS-MAMA primer. A small study of 12
F. tularensis-specific Melt-MAMAs, designed according to Li et al
guidelines, resulted in a 41.6% initial success rate. This rate is
slightly less than the ,50% initial success rate of Melt-MAMAs
designed without implementing the guidelines. These similar
results between the two approaches suggest that the Li et al
guidelines offer no advantage to competitive Melt-MAMAs and
may even slightly reduce assay success rates.
Successful assay optimization by altering the primer
ratios
Despite the enhanced allele specificity endowed by the
destabilizing mismatch design [15], our Melt-MAMAs often
encountered costly design failure rates using equal primer
concentrations. Accurately genotyping Melt-MAMAs succeed
because the two AS-MAMA primers amplify only their respective
allelic templates by out-competing the non-allelic alternate AS-
MAMA primer (Figures 2 & 3). Although ,45% of our assays
behave in concordance to this prediction when at equal primer
concentrations, our studies also show that equal primer stoichi-
ometry caused ,30% of our assays to perform poorly. Among the
185 Melt-MAMAs reported here, 72 assays displayed mild to
severe cross-allele primer hybridization and resulted in poor
(viewed as two melt profiles for a single DNA template; data not
shown) to inaccurate allele discrimination by at least one of the
AS-MAMA primers (Figure 4A). To rescue these poor performing
assays, the concentration of the AS-primers were altered such that
the concentration of the problematic allele-specific MAMA primer
was less than the alternate ‘‘weaker performing’’ allele-specific
MAMA primer by 2x, 3x, or 4x (See Methods; Figure 4B). The
degree of reduction of the problematic AS-MAMA primer
depended on the severity of the cross-reactivity. This strategy of
altering primer concentrations resulted in accurate genotyping for
both allelic templates (Figure 4B) in all 72 cases. Unexpectedly, we
observed a pattern in which the more efficient AS-MAMA primer
(67 out of 72) was the one labeled with the GC-clamp (Figure 4A).
Additional validation studies across a known panel of diverse
samples that represent each allele further demonstrated the fidelity
of these ‘‘altered primer’’ assays (data not shown). Following a
standard assay validation strategy that includes conditions of
altered primer ratios (Figure 5), increased our total assay design
success rate from 46% to 87% (Table 1). Twenty-eight other
assays failed for miscellaneous reasons and could not be corrected
by altering the primer ratio. This final category of SNP assays
required more dramatic redesign strategies, such as primer design
from the opposite strand, or abandonment of the SNP locus.
However, abandonment was rare and, in our hands, Melt-MAMA
success was comparable and possibly superior to the successful
design rate of Dual Probe TaqMan assays, which also suffer from
SNP locus design constraints [23].
As the design of two-nucleotide mismatch feature alone is not
always sufficient to create the efficiency differential required for
SNP discrimination at equal primer concentrations, Melt-MAMA
performance is not solely determined by mismatches at the 39-end.
This finding has been previously reported [29,30]. We observed
that the presence of the GC-clamp appeared to influence the
efficiency differential of Melt-MAMAs. The GC-clamp dispro-
portionately favored higher efficiency (67 out of 72 assays) when
primers were at equal concentrations while matched with the non-
allelic DNA template. Taken together, these results suggest that
the efficiency differential required for successful Melt-MAMAs is a
product of both the nature of the mismatch at the 39 end and the
sequence of the entire primer. The GC-clamp appears to have a
net effect of increasing the efficiency of many, but not all, assays.
The exact mechanism for this observation is not well understood,
could be multi-factorial, and was not tested in this study.
Allele-Specific PCR (AS-PCR) has been slow to gain popularity
perhaps due to the ,50% failure rate reported by others [12,23]
and observed in our study when assays are not further optimized by
altering primer concentrations (Table 1). Chemically modifying
primers to overcome this traditionally high rate of AS-PCR assay
failure is an effective but expensive strategy [31–33]. Primer design
guidelines to maximize the specificity of AS-MAMA primers for
Table 1. Melt-MAMAs targeting specific groups within eight pathogen species.
Bacterial Pathogen
%GC
content
Genome
size
Assay
Success Ratea
Total
Assays
Total assay
successb Failedc
Increased
primer non
GC-clampd
Increased
primer
(GC-clamp)d
Francisella tularensis 30% 1.9 Mb 98% 51 50 1 24 2
Bacillus anthracis 35% 5.2 Mb 87% 23 20 3 11 0
Yersina pestis 47% 4.6 Mb 81%,100%b 22 22b 4 0 0
Escherichia coli 50% 5.0 Mb 83% 6 5 1 0 0
Burkholderia
pseudomallei
68% 7.3 Mb 40% 10 4 6 0 0
Burkholderia mallei 68% 5.8 Mb 72% 25 18 7 12 0
Brucella suis 56% 3.2 Mb 83% 12 10 2 6 0
Coxiella burnetii 42% 2 Mb 66%,89%b 36 32 4 14 3
aFirst design attempt and altered primer ratio optimization.
bSuccess after combining first or second design attempts and altered primer ratio optimization.
cFailed after first design attempt.
dAssays that required altered primer concentration ratios.
doi:10.1371/journal.pone.0032866.t001
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non-competitive MAMAs exist [16], but our experiments suggest
that these guidelines are poorly relevant to competitive Melt-
MAMAs. Altering primer concentrations to generate efficiency
differentials between AS-MAMA primers when competing for the
same template have been used to optimize assays in other studies
[29] and have been used with Dual Probe TaqMan assays to rescue
poorly discriminating assays (data not shown). This simple strategy
corrected assays that suffered from severe primer cross-allele
genotyping and markedly improved our initial assay-design success
rate. Our success rate is now comparable to Dual Probe TaqMan
assays [23]. Anecdotally, more experienced assay design teams
frequently exceed this assay-design success rate and we have
achieved near 100% success on some projects. Our overall rate of
87% is a conserved program-wide rate. On specific projects where
Figure 1. Melt-MAMA approach to SNP genotyping. A) Allele-specific (AS) primers are designed to detect the two alleles at a SNP locus on
DNA template. These primers work in concert with a third common primer to generate a PCR amplicon. Depending on the template, only one of the
AS primers will generate the amplicon in concert with the common primer. The ability to differentiate amplicon derived from each allele-specific
primer is accomplished by the GC-clamp. The success of one versus the other is evaluated by melt-dissociation analysis, which is facilitated by the GC-
clamp on the 59 end of the one AS primer. B) Allele-specificity of primers is achieved by the incorporation of two independent design features that
work nearly synergistically. First, the primer is designed in which the 39 ultimate nucleotide directly overlaps the SNP locus in perfect complement.
Second, allele-specificity is strengthened by engineering a mismatch at the antepenultimate position of the primer (MAMA primer) that uniquely
differs in base composition to the template and alternate AS primer. This difference creates two mismatched nucleotides in the 39 region of the
primer for the non-allelic template, but only one difference in the correct allele template. This dramatically improves specificity by destabilizing the
39 end of the non-allelic primer-template complex. Once a single round of PCR amplification has occurred, the antepenultimate difference is
incorporated into the template for efficient subsequent rounds of amplification. Hence, the initial priming specificity is critical to accurate
genotyping. Because the AS primers are added together in one reaction, they compete for priming, which also increases genotype fidelity over two
independent reactions.
doi:10.1371/journal.pone.0032866.g001
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multiple design attempts were made, we were able to achieve an
overall assay success rate of $90%.
The effects of genome size and %GC content on assay-
design success rate
We also investigated the effects of genome size (1.9 Mb–7.3 Mb)
and %GC content (30%–68%) of the eight pathogen species to
assess the success rate of Melt-MAMA development (Table 1). Our
results demonstrated that assay-design success rate can be affected
by these two genomic variables. Species with small genomes and
low GC content, such as Francisella tularensis (1.9 Mb; 30%GC), had
a markedly higher success rate of assay development than
pathogens with large genomes and high GC content, such as
Burkholderia pseudomallei (7.3 Mb; 68% GC) (98% and 40% success,
respectively; Table 1). The negative impact of large genome size on
assay success rate was illustrated by the comparison of the genomes
of Burkholderia pseudomallei (7.3 Mb) and Burkholderia mallei (5.8 Mb).
Despite their identical 68% GC content, assay success rates for
these species markedly differed (40% and 72%, respectively;
Table 1). Higher %GC content also appeared to negatively impact
the success rate as illustrated by the comparison of the genomes F.
tularensis (30% GC) and Coxiella burnetii (42% GC). Despite
comparable genome size (1.9 Mb and 2 Mb, respectively), their
assay-design success rates moderately differed (98% and ,89%,
respectively). These results suggest that the two independent
variables of genome size and %GC content each contribute to
assay success rates. The final assay-design success rate of the four
remaining pathogens with mid-size genomes (3.2 Mb–5.2 Mb) and
moderate %GC content (35%–56%) varied (83%–100%). Taken
together, these results suggest that the final assay-design success
rate of Melt-MAMAs is influenced by the genomic size and %GC
content of the target organism in an independent and weighted
manner. These observations are consistent with publications
reporting that organisms with large genome size and high GC
Figure 2. The principle of the Melt-MAMA PCR reaction. Four different scenarios involving two alternate SNP allele templates (I & II vs. III & IV)
and the interaction of Allele-Specific (AS) PCR amplification using MAMA primers. The annealing of AS-MAMA primers to their allelic templates is
shown with one primer labeled with a 59 GC-clamp (Ia) whereas the other is not (IVa). (Ib and IVb) Taq Polymerase extends from the 39 matched AS-
MAMA primer despite the antepenultimate destabilizing nucleotide. (Ic and IVc) The second PCR cycle replicates from a newly synthesized DNA
template made in the previous step (Ib and IVb). With the synthesized DNA serving as the template, a perfect primer-template complex is formed
eliminating the antepenultimate destabilizing mismatch observed in Iab and IVab. At PCR endpoint (Id and IVd), the amplicons generated from the 39
matched AS-MAMA primer greatly outnumbers the amplicons generated by the mismatched AS-MAMA primer. Temperature-dissociation curve plots
(Ie and IVe) of each AS-PCR product (Iabcd, IIab and IIIab, IVabcd), showing the fluorescent intensity and the rate of fluorescent intensity change
(derivative) as a function of temperature. For each allelic template reaction (I & II vs. III & IV), the melt profiles (Ie and IVe) show only a single change in
fluorescent intensity. This indicates the amplification of the perfect-matched amplicon and little to no amplification of the mismatched amplicon. The
GC –clamp ‘‘labeled’’ amplicons dissociate at higher temperatures (,3uC to 5uC) than non-GC amplicons. Nonproductive primer annealing is shown
for an AS-MAMA primer (IIa) and a GC-clamp AS-MAMA primer (IIIa) binding with their respective corresponding mismatched templates. The lack of
Watson-Crick base pairing at two 39 positions (the antepenultimate nucleotide at the 39 end) of the AS primer introduces instability at this region (IIb
and IIIb). This prevents efficient extension by the polymerase, which retards or prevents product amplification (Ie and IVe).
doi:10.1371/journal.pone.0032866.g002
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content tend to have poorer rates of successful PCR amplification
[34–37]. That said, numerous publication on the MAMA
technology used human genomes [17,18,20], which is large in size.
Melt-MAMAs are not suitable for genotyping extremely
low level DNA template amounts
A concern with genotyping assays is whether they are accurate
at very low template concentrations, yet to our knowledge this
variable has not been extensively tested with Melt-MAMA.
Therefore, we investigated the accuracy and sensitivity of Melt-
MAMA against a wide range of DNA template amounts using
three assays that differentiate six genetic populations of the
pathogen Bacillus anthracis. Ten-fold serial dilutions of SNP
polymorphic allele DNA templates (ancestral and derived,
respectively), of equal DNA amounts based on TaqMan assays
(Figure 6) and NanoDropTM measurements were screened on
three Melt-MAMAs targeting B. anthracis lineages A.Br.003,
A.Br.004, and A.Br.006 [4]. Dual Probe TaqMan assays are
reported to detect DNA templates at single genomic equivalent or
copy levels [4,5,38] and our TaqMan assay result indicates that
Figure 3. Real-time PCR amplification and dissociation (melt) curve plots. B. anthracisMelt-MAMA SYBRH Green assay targeting the A.Br.004
genetic clade. (A & C) The amplification of two alleles are illustrated for haploid template (Bacillus anthracis) possessing an ‘A’ polymorphic SNP-state
or ‘G’ state. Each amplification plot represents a single PCR reaction containing a reverse ‘‘common’’ primer and two allele-specific MAMA primers.
The AS-MAMA primers anneal to the same template target and then compete for extension across the SNP position. The polymerase-mediated
extension rate of the 39match AS-MAMA primer (perfect primer-template complex) exceeds that of the 39mismatched MAMA primer (mismatched
primer-template complex), thus the perfect match primer-template complex outcompetes the mismatched primer-template complex and dominates
the PCR amplification. (B & D) Plots of the temperature-dissociation (melt) curve of the final PCR products for the two allele templates are shown next
to their respective amplification plots (green arrows). Allele-specific PCR products are easily differentiated through temperature-dissociation (melt)
curve analysis, which is conferred by the GC-clamp engineered on one of the AS-MAMA primer.
doi:10.1371/journal.pone.0032866.g003
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levels less than a single copy can be detected in a fashion consistent
with stochastic sampling processes (Figure 6). The A.Br.003 Melt-
MAMA experiments demonstrated consistent amplification and
accurate genotypes for the ancestral and the derived DNA
templates at an amount of ,115 ng–,11.5 fg (,1.96107 to
,1.9 genome copies; seven-orders of magnitude range) (Figure 7).
This Melt-MAMA was one order of magnitude less sensitive than
the TaqMan assay (Figures 6 & 7). The A.Br.003 Melt-MAMA
displayed consistent amplification and correct genotype calls to
low level DNA amounts of 11.5 fg (,1.9 copies). Below this
amount (,1.15 fg), we observed a combination of correct allele
calls, non-specific amplification, or complete amplification failures
(Figure 8). For example, a single spurious amplification had a
unique melt-profile that did not match the profile of either allele,
indicating non-specific amplification (Figure 8D, red arrow).
Without close scrutiny of this unique profile, which appears
similar to an ancestral genotype profile, it is possible that this
profile would be assigned an incorrect allele call. Due to a single
spurious amplification observed at , ,1 copy, and in the event
that such spurious amplification remains probable at,11.5 fg (,2
copies), we conservatively consider the lowest limit for this
A.Br.003 Melt-MAMA to be 115 fg (,19 copies) rather than at
,1.9 copies. Interestingly, all negative controls (n = 34) failed to
amplify by 50 cycles (Figure 8, negative controls n= 8; data not
shown; negative controls n = 26).
Other Melt-MAMAs display less sensitivity to low level DNA
amounts. The A.Br.006 [4] Melt-MAMA was two orders of
magnitude less sensitive than the TaqMan assay (Figures 6 & 9)
and one order of magnitude less sensitive than the A.Br.003 Melt-
MAMA (Figures 7, 8, 9, 10). The A.Br.006 Melt-MAMA
consistently genotyped allelic templates ranging from 1.96107 to
19 copies (,115 ng to ,115 fg) (six-orders of magnitude range)
(Figures 9A & B). At DNA amounts of # ,11.5 fg (,1.9 copies),
we observed either correct allele calls (Figure 10) or non-specific
(spurious) amplification with unique melt-profiles that did not
perfectly match the profile of either allele types (Figures 10C & D).
We thus consider the lowest limit for this A.Br.006 Melt-MAMA
to be at ,115 fg (,19 copies) displaying a CT range of 31–35.
Most of the negative controls (n = 36) amplified at a CT range of
40–50, generating non-specific products with melt profiles that
Figure 4. Assay optimization by altering the primer ratios. Primer design does not always result in perfectly matched combinations and
additional improvement can be achieved by altering primer ratios. The derivative plots of the temperature-dissociation (melt) curves of two PCR
products amplified in a F. tularensis assay are shown. Each product was amplified from genomic template with one of the two allele SNP-states (A or
G). A) Under equal primer concentrations, this Melt-MAMA mis-genotyped the ‘G’ allele gDNA template because the G specific primer was more
efficient than the A specific primer. In this case, the mismatched primer for the ‘G’ SNP allele state outcompeted the perfect matched primer, resulting
in the amplification of the incorrect allele-specific PCR product. B) Primer ratios were then altered so that the matched primer for the ‘‘G’ SNP state
was four times more concentrated than the respective mismatched primer. Under these unequal primer concentrations, the ‘G’ allele gDNA template
accurately genotyped without the disruption of the accurate genotyping functions of the ‘A’ allele gDNA template.
doi:10.1371/journal.pone.0032866.g004
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differed from profiles of the expected two allelic states (Figures 9C
& D, negative controls n= 8; data not shown, negative controls
n = 26).
Melt-MAMAs and TaqMan assays both can suffer from non-
specific spurious background amplification that stochastically occurs
when DNA amounts are at extreme low levels (see Figures 8–10).
These non-specific amplifications are generated from primers
interacting with each other and/or at non-specific regions on the
genome template. At prolonged cycle times (35–50), they are
detected by SYBRGreen, but not inTaqMan assays.This difference
in spurious product detection between these two assay types is based
on the non-specific nature of SYBRGreen and the specific nature of
the internal TaqMan probes. SYBR Green binds to all dsDNA
which contrasts to TaqMan probes in the Dual Probe TaqMan
assays which detects only target product. In light of the probable
event of generating spurious product when DNA amounts are
extremely low, we are highly conservative with our estimates of assay
sensitivity.We routinely exclude products with amplification greater
than 32 CT values. We discard assays that show amplification of
negative controls with CT values less than 35. We emphasize the
importance of careful scrutiny of all data to assure the exclusion of
products from the rare spurious amplification and the inclusion of
positive template controls with every experiment.
Sensitivity can depend on allelic template type for some
Melt-MAMAs
The sensitivity of A.Br.003 and A.Br.006 assays were equal
regardless of the allelic state of the template (Figures 7–9A & B).
This characteristic is not true for all Melt-MAMAs. The sensitivity
limit of A.Br.004 assay depends on which allelic template is in the
reaction. The A.Br.004 ancestral AS-MAMA primer consistently
amplified and genotyped ,1.9 copies (11.5 fg) of ancestral
template, whereas the derived AS-MAMA primer with the same
amount of derived DNA template (1.9 copies or,11.5 fg) failed or
generated spurious products (indicated by unique melt-profiles,
data not shown). The derived AS-MAMA primer consistently
amplified and accurately genotyped ,19 copies of derived
template. These differences indicated that the ancestral AS-
MAMA primer has one order of magnitude more sensitivity to
the ancestral template than the derived AS-MAMA primer has for
the derived template (,1.9 copies and ,19 copies, respectively).
Despite the sensitivity differences among AS-MAMA primers for
their respective allelic templates, the efficiency differential between
the AS-MAMA primers for the identical template remain firmly
intact. For accurate SNP genotyping capability, the ancestral AS-
MAMA primer would have greater efficiency with the amplifica-
tion of the ancestral DNA template compared to the derived
Figure 5. Melt-MAMA validation work flow. This figure shows the sequential steps involved in validation of Melt-MAMA assays. After SNP
selection (step I), Melt-MAMA are designed so that the amplicon is ,100 bp in length (step II). Assays are screened across ancestral and derived DNA
templates under 3 primer ratio conditions where 1:1 represents equal primer ratio, 4:1 represents ancestral primer 4x and derived primer 1x, and 1:4
represents ancestral primer 1x and derived primer 4x (step III). Five outcomes are indicated (step III a–e). Based on the performance of B. anthracis, F.
tularensis, and Y. pestis assays, 70–80% Melt-MAMAs accurately genotyped at one of the tested primer ratio condition (step IIIa). These successful
assays were immediately screened on a diversity panel of DNA samples (step IV). The remaining assays (20–30%) resulted in one of the other four
outcomes (step III b–e). Each outcome required additional specific validation steps to determine the optimal PCR conditions or the need to abandon
the SNP altogether. Our overall design success rate increased from 46% to 87%.
doi:10.1371/journal.pone.0032866.g005
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AS-MAMA primer for this same ancestral DNA template.
Likewise, the opposite is true. For example in the A.Br.004 assay,
if ,2 copies of a derived template is in the reaction (an amount
where this assay fails), the derived AS-MAMA primer lacks the
sensitivity for this copy amount by one order of magnitude and the
ancestral AS-MAMA primer lacks the sensitivity for this amount of
derived template by ,2 orders of magnitude. The event of mis-
genotyping DNA at extremely low amounts remains improbable
due to this efficiency differential.
Two-Locus (duplexed) Melt-MAMA
To further enhance the cost-effectiveness of Melt-MAMAs, we
developed a two-locus duplex Melt-MAMA targeting two different
SNPs that define two clinically relevant subspecies withinF. tularensis
(F. tularensis subsp. tularensis and F. tularensis subsp. holarctica). Four
Francisella strains – representing threedifferentF. tularensis subspecies
and the genetic near neighbor F. novicida (Figure 11A), were
genotyped todemonstrate theutility of this assay.Each strain showed
clear, unambiguous melt-dissociation profiles that matched the
expected genotype for each respective strain (Figure 11Bi–iv).
Additional screening across a small panel of geographically and
genetically diverse set ofF. tularensis isolates comprised of highquality
genomicDNAresulted inperfectagreementwithgenotypesobtained
from single-plex assays and multi-locus variable number of tandem
repeats assay (MLVA) [39] (data not shown). This 100% agreement
between independent approaches demonstrates the proof of concept
Figure 6. TaqMan assay performance at a broad range of DNA amounts. A B. anthracis TaqMan assay was used to screen the polymorphic
‘G’ or ‘A’ DNA templates (ancestral and derived, respectively) used in the B. anthracis Melt-MAMAs. (A & B) The respective amplification plots of
genomic DNA of ‘G’ allele and ‘A’ SNP allele templates show the amplification curves of templates titrated in ten-fold serial dilutions and in replicates
of eight. The number assigned to each amplification curve (1–9) denotes the DNA amount for the starting template. (C) Both genomic template types
were of equal amounts. The consistency of amplification dropped with lower amounts of initial template, but the dilution levels containing less than
a single copy (B. anthracis single copy,6 fg) was still detectable in some reactions. Detection of low-level DNA template by TaqMan assays is subject
to stochastic sampling effects, which is predictable using a Poisson distribution [4].
doi:10.1371/journal.pone.0032866.g006
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that duplex Melt-MAMAs are effective genotyping assays and a
viable cost-saving strategy.We estimate that the consolidation of two
SNP markers into a single Melt-MAMA duplex assay reduced
reagent usage and labor by,50%.
Allele-Specific MAMA genotyping based upon agarose
sizing
Genotyping samples using Melt-analysis requires somewhat
sophisticated real-time PCR instruments, which come at a heavy
upfront cost and require technically trained personnel. Because the
Melt-MAMAs presented here are based exclusively on unlabeled
primers of distinctly different lengths, as expected, we determined
that our assays are amenable to the lower technological approach of
conventional PCR coupled with agarose-gel electrophoresis plat-
form (Figure 12). We obtained these results using primer ratios and
template concentrations identical to those used on real-time
instruments. For some of our assays, we adjusted the annealing
temperature from 60 to 55uC, which improved the amplification
Figure 7. Genotyping over a broad range of DNA amounts. Melt-MAMA genotyping accuracy is not diminished at lower amounts of DNA, even
at near-single copy for some assays. The sensitivity of individual melt-MAMAs varies greatly. This B. anthracis melt-MAMA (A.Br.003 clade) [4] accurately
genotyped DNA regardless of starting amounts as long as it was sufficient to support amplification. (A & B) The respective amplification plots of genomic
DNA of ‘G’ allele and ‘A’ SNP allele templates show the amplification curves of templates titrated in ten-fold serial dilutions and in replicates of eight. The
number assigned to each amplification curve (1–8) denotes the DNA amount for the starting template. (C) The temperature-dissociation (melt) curve
derivatives for all initial template amounts are shown (numbers denote DNA amount shown). This panel illustrates that genotyping accuracy was not
affected by DNA amounts, even at near-single copy levels. Similar to TaqMan assays, the detection of low levels of DNA template by Melt-MAMA is also
subject to stochastic sampling effects (B. anthracis single copy ,6 fg), which is predictable using a Poisson distribution [4].
doi:10.1371/journal.pone.0032866.g007
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and detection on agarose gels. We believe this was due to the
difference in MgCl2 concentrations between SYBR Green master
mix (Applied Biosystems, Foster City, CA) and our conventional
PCR master mix (see methods). Commercially pre-made SYBR
Green master mixes typically use high concentrations of MgCl2 to
overcome the inhibitory property of SYBR Green dye [40]. On an
agarose-gel platform, we resolved allelic differences through the
differential amplicon size made possible by the 19 bp GC-clamp
label. PCR products generated by real-time PCR from two different
pathogen assays, F. tularensis type A-specific and a B. anthracis
A.Br.004-specific, were viewed by Melt-analysis (Figures 12A & C).
PCR products from these same assays were generated by
Figure 8. Competition between specific and non-specific amplification at extremely low level DNA amounts. With extremely low-level
DNA amounts (,,2 copies), stochastic, spurious, non-specific amplification could outcompete allele-specific amplification. The Bacillus anthracis
melt-MAMA targeting the A.Br.003 clade [4] stochastically amplified allele-specific product and non-specific spurious products at amounts of less than
a single copy (,0.19 copies). (A and B) The respective amplification plots of genomic DNA of ‘G’ allele and ‘A’ SNP allele templates show the
amplification curves of templates at 1.15 ng and at two low level ten-fold dilution series (near-single copy and less than a single copy) in replicates of
eight. The number assigned to each amplification curve (3, 8–9) denotes the DNA amount for the starting template. (C & D) The temperature-
dissociation (melt) curve derivatives for the 1.15 ng and lowest template amounts are shown. This panel illustrates that genotyping accuracy was not
compromised at DNA template amounts near single copy level, but spurious amplification was observed in dilution points below this level. This
spurious amplification had a unique melt-profile that did not match the profile of either allele types (red arrow).
doi:10.1371/journal.pone.0032866.g008
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Figure 9. Genotyping over a broad range of DNA amounts. Melt-MAMA sensitivity to low level DNA amounts varies greatly among different
assays. B. anthracis melt-MAMA targeting the A.Br.006 clade [4] accurately genotyped DNA at amount ,19 copies. (A & B) The respective
amplification plots of genomic DNA of ‘G’ and ‘A’ SNP allele templates show the amplification curves of templates titrated in ten-fold serial dilutions
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conventional PCR, under identical reaction conditions, and
visualized on a 3% (Figure 12B) and 2% agarose gel (Figure 12D),
respectively. Allele-type was differentiated based on amplicon size
differences, which were clearly distinguishable (Figures 12B & C).
An additional set of 22 B. anthracis AS-MAMAs (initially developed
as Melt assays; see subset in Table S1), tested by conventional PCR
and genotyped by agarose sizing (data not shown) demonstrated the
same results shown in Figure 12.
The successful development of AS-MAMAs on an agarose-gel
platform [29,30] and on capillary electrophoresis (CE) [41] have
been reported. On an agarose-gel platform the allele-specific size
differences are achieved by the incorporation of an AT-rich 59 tail
to one of the AS-MAMA primers to provide added length. In
contrast, on the CE platform allele-specificity is based on
differential sequences encoded at the 59tail of each AS-MAMA
primer. This facilitates the differential incorporation of allele
specific fluorescent dyes, which can be subsequently visualized on
CE, a technology termed as CE universal tail MAMA (CUMA)
[41]. We developed AS-MAMAs that function equally well on real-
time instruments and conventional PCR coupled with agarose
sizing under identical PCR conditions. The only exception was the
need to reduce the annealing temperature in some assays due to
master mix differences. In theory, Melt-MAMA could be
transferred to CE platform since this too is principally based on
conventional PCR. Our single attempt of Melt-MAMA to CUMA
conversion resulted in success indicated by the retention of accurate
genotyping (data not shown). The amenability of assays across these
multiple platforms would allow assay technology to transfer
between research facilities without additional redesign or extensive
assay optimization. This is particularly valuable as genotypic data
from rudimentary public health labs can be integrated readily with
databases generated in technically advanced genome centers. High
capacity screening is not needed in many regional situations, but
the results need to be directly comparable to global databases.
Synthetic allele-specific templates
Every AS-MAMA experiment must include genotyping of
positive control templates possessing the derived and ancestral
SNP states. This poses a challenge in that access to DNA templates
that can appropriately serve as positive controls for a given assay
may not be possible for every laboratory. This problem could
hamper the assay technology transfer between collaborating
research facilities. To address this issue, we have developed an
approach to create SNP-polymorphic synthetic positive controls for
any given AS-MAMA (See Figure S1 and Table S1). These
synthetic positive controls are PCR amplicons generated by allele-
specific unlabeled primers and they can be performed in-house
within any research facility capable of conventional PCR (see
methods). We successfully generated synthetic positive control
templates for 20 assays that serve as both Melt-MAMAs and
Agarose MAMAs (Table S1).
In conclusion, Melt-MAMAs are highly effective SNP genotyp-
ing tools that are approximately fourteen times less expensive than
Dual Probe TaqMan assays. The studies presented here identified
specific strategies and work flow (Figure 5) that effectively
increased assay success rate at the first design attempt, providing
performance that rivals the success rate of Dual Probe TaqMan
assays. These specific strategies include 1) designing the destabi-
lizing mutation to have a unique base character that differs from
the base character of the genomic DNA template and the alternate
AS primer and 2) altering the ratios of AS primer concentrations
to correct poorly genotyping assays. We also described the size
advantage of the GC-clamp label that permits amenability of
identical assays on two frequently used but very different
instrumentation platforms. Data presented here advanced our
knowledge of the capacities and design principles of Melt-
MAMAs, which will maximize the successful application of this
technology throughout the wider scientific community.
Methods
Melt-MAMA Design
All Melt-MAMAs used in this study were designed using Primer
Express 3.0 software (Applied Biosystems, Foster City, CA) or a
free on-line primer design software by Premier Biosoft (http://
www.premierbiosoft.com/netprimer/). Assay design consisted of
four features: 1) Two AS forward primers, where the 39 ends
correspond to one of the allele-states for the SNP locus, and a
common reverse primer, 2) a deliberate ‘destabilizing’ mismatch at
the penultimate or antepenultimate base position (–2 or –3,
respectively from the 39-end), 3) a GC-clamp at the 5-end of one of
the allele-specific forward primers (12–19 bp consisting of a
GGGGC repeat pattern), and 4) a small PCR product (60 bp–100
bp) (Figures 1 & 2). The GC-clamp served as a label that would
permit easy differentiation between the two allele-specific PCR
products, based on differences in GC content. This differentiation
is based on dissociation curves (melt analysis) [17,20,21]
(Figures 3B & 3D). Typically the ‘‘derived’’ AS-MAMA primer
was labeled with the GC-clamp. Each Melt-MAMA reaction
mixture (7 ml or 10 ml) contained 1x SYBR Green PCR master
mix (Applied Biosystems, Foster City, CA), two forward AS
primers, a common reverse primer, and 1 ml of DNA template at
,1ng/ml. DNA templates were produced from Whole Genome
Amplifications (WGA; Qiagen, Valencia, CA) or genomic DNA
extracted by various types of preparations (standard heat soak or
chloroform preparations). Melt-MAMAs were performed on an
Applied Biosystems 7900HT Fast real-time PCR system with SDS
v2.3 software. Thermocycling parameters were 50uC for 2 min,
95uC for 10 min, and then cycled at 95uC for 15s and 55uC–60uC
(dependent on assay; see Table S1) for 1 min for 33 cycles. End-
point PCR products were subject to melt analysis using a
dissociation protocol comprising 95uC for 15 s, followed by
incremental temperature ramping (0.2uC) from 60uC to 95uC.
SYBR Green fluorescent intensity is measured at 530 nm at each
ramp interval and plotted against temperature. Melt-MAMAs
(n= 185) were designed by multiple research teams targeting eight
diverse bacterial pathogens (Table 1). A subset of Melt-MAMAs
(targeting different genetic groups of F. tularensis and B. anthracis)
were used to illustrate key functional aspects of this technology
(Table S1). The SNP signatures in F. tularensis specific assays
targeted sublineages within the B.Br.013/014 subclade (Birdsell &
and in replicates of eight. The number assigned to each amplification curve (1–7) denotes the DNA amount for the starting template. (C & D) The
temperature-dissociation (melt) curve derivatives for all initial template amounts are shown (numbers denote DNA amount shown). Panels C and D
illustrates that genotyping accuracy is obtained across a broad range of DNA template amounts of,115 ng to 115 fg. Assay sensitivity to template is
limited to ,19 copies and above. An inherent characteristic of this assay is the occurrence of spurious amplification at extended cycle times (.35) in
the absence of template as indicated by the NTCs. Melt-MAMAs detecting low level DNA are subject to stochastic sampling effects (B. anthracis single
genome copy ,6 fg), which is predictable using a Poisson distribution [4].
doi:10.1371/journal.pone.0032866.g009
Function of a Cost-Effective SNP Genotyping Assay
PLoS ONE | www.plosone.org 13 March 2012 | Volume 7 | Issue 3 | e32866
Keim, unpublished data) and the SNP signatures in B. anthracis
assays targeted the major lineages previously described [4].
Assay optimization through altering the primer ratios
To efficiently determine the optimized condition for each assay,
a standard work flow approach for assay validation was followed
(Figure 5). Initial validation included three different reactions
consisting of three ratios of AS-MAMA primers (ancestral and
derived, respectively) at 1:1, 4:1, and 1:4 run at a 60uC annealing
temperature. Adjustments for subsequent rounds of assay valida-
tion were determined following the initial results. Readjustments
included the less or more severe ratio alteration of the AS-primers
(2:1 and 1:2; 6:1 and 1:6) or testing at lower or higher annealing
temperatures (55uC–62.5uC). Assays were deemed valid when they
accurately and consistently genotyped both allelic DNA templates
under identical conditions.
Figure 10. Competition between specific and non-specific amplification at low level DNA amounts. The B. anthracis Melt-MAMA
targeting the A.Br.006 clade [4] stochastically amplified allele-specific product and non-specific spurious products at amounts of less than,19 copies.
(A & B) The respective amplification plots of genomic DNA of ‘G’ allele and ‘A’ SNP allele templates show the amplification curves of templates at
1.15 ng and at two low level ten-fold dilution series (,19 copies and near a single copy) in replicates of eight. The number assigned to each
amplification curve (3, 7–9) denotes the DNA amount for the starting template. (C & D) The temperature-dissociation (melt) curves derivatives for the
1.15 ng and lowest template amounts are shown. This panel illustrates that assay sensitivity to template is limited to ,19 copies and above. Below
this template amount, spurious amplification is possible and difficult to differentiate from template-specific amplification.
doi:10.1371/journal.pone.0032866.g010
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Design success rates of assays
To measure the successful design rate of Melt-MAMAs, we
recorded the number of successful assays after the first design
attempt on 185 assays targeting eight diverse bacterial pathogens
(Table 1). Assays that successfully functioned after primer ratio
alteration were included in this category. To determine if design
success rate is dependent on genome size and GC content of the
target organism, we recorded the design success rate of assays per
target organism with discrete genome size and GC content
(Table 1).
Assay Robustness and Sensitivity
We tested the sensitivity and genotyping accuracy (robustness) of
a small subset of Melt-MAMAs (three B. anthracis specific) across a
Figure 11. Two-Locus (duplexed) Melt-MAMA development. (A) A phylogenetic topology of the three subspecies of F. tularensis rooted with
F. novicida. The SNP-signatures specific for the two pathogenic subspecies of F. tularensis (indicated by black bars) were incorporated into Melt-
MAMAs. The table (right) indicates expected allele states (derived and ancestral) for strains from each F. tularensis subspecies represented on the
topology; F. novicida would have the same allelic states as F. tularensis subsp. mediasiatica. (Bi–iv) Temperature-dissociation (melt) curves (derivative)
of allele-specific PCR products from F. tularensis strains amplified in the duplexed assay (Type A and Type B). Each profile show two melt-curve peaks
generated from a single F. tularensis strain. Each peak corresponds to the allele-specific PCR product for a single SNP-locus in the duplexed assay.
doi:10.1371/journal.pone.0032866.g011
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broad range of DNA concentrations (115 ng–1.15 fg) by perform-
ing 10-fold serial dilutions in replicates of eight (Figures 6–10).
Duplex Melt-MAMA
Two F. tularensis assays specific to different genetic groups (F.
tularensis subsp. tularensis and F. tularensis subsp. holarctica) were
combined into a single duplex assay (Figure 11; Table S1). To
permit the proper dissociation temperature (Tm) spacing of all AS-
PCR products in this duplex assay a GC-clamp was added on to
the common reverse primer of the F. tularensis subsp. holarctica assay
in addition to one of the allele-specific MAMA primer (See assay
design on Table S1). In contrast, the F. tularensis subsp. tularensis
assay contained a GC-clamp only on one of the allelic-specific
MAMA primers (Table S1). To fully validate the duplex assay, we
screened it across a small panel of geographically diverse F.
tularensis DNA samples (data not shown).
Agarose MAMA
We converted a subset of our Melt-MAMAs to a lower
technology platform using conventional PCR coupled with
agarose gel electrophoresis (Agarose-MAMAs) (Table S1). F.
tularensis subsp. tularensis and B. anthracis A.Br.004 Melt-MAMAs
Figure 12. Allele-Specific MAMAs Based Upon Agarose Sizing. Allele-specific SNP MAMAs from two pathogen species were transferred from
a real-time PCR instrument (A & C; Melt-MAMA) to conventional PCR coupled with agarose gel electrophoresis (B & D; Agarose-MAMA) under identical
assay conditions. Genotypes from Melt-MAMAs are determined by temperature-dissociation (melt) curves, whereas genotypes from Agarose-MAMAs
are determined by the amplicon size differences.
doi:10.1371/journal.pone.0032866.g012
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were used to illustrate this size-based genotyping method
(Figure 12). Selected assays possessed a 19 bp GC-clamp to
provide sufficient size difference among AS-PCR products visible
on 3% and 2% agarose gels. The conventional PCR master mix
comprised two forward AS primers and a common reverse primer
starting at 0.2 mM (IDT, San Diego, CA), 1x PCR buffer without
MgCl2 (Invitrogen, Carlsbad, CA), 2 mM MgCl2 (Invitrogen,
Carlsbad, CA), 200 mM of each dNTPs (Invitrogen, Carlsbad,
CA), 0.8 units of Platinum Taq DNA polymerase (Invitrogen,
Carlsbad, CA), 1 ml of template at ,1ng/ml, and molecular grade
water to a final volume of 10 ml. Agarose-MAMAs were
performed under the following conditions: PCR amplifications
were conducted on a MJ Research 96 well block thermal cycler
DNA engines equipped with hot bonnets. PCRs were raised to
94uC for 5 min to denature the DNA and to activate the hot-start
Taq DNA polymerase, then cycled at 94uC for 30 sec, 55uC–
62.5uC (depended on assay) for 30 sec, 72uC for 30 sec, with a
final extension at 72uC for 5 min. The PCR amplicons and a 100
bp ladder (Invitrogen, Carlsbad, CA) were electrophoresed at
100 V for 90–110 minutes on a 2% or 3% agarose gel (Fisher
Scientific, Pittsburgh, PA) prepared in 1x TAE and visualized with
SYBR Safe (Invitrogen, Carlsbad, CA).
Synthetic Positive Control templates
Each allele-specific synthetic positive control is an amplicon
generated by conventional PCR using the same starting template
(Figure S1). The allele SNP-state of the synthetic positive control is
constructed by the base identity of the 39 end of the forward primer.
This is the reasonwhy the same starting genomicDNA template can
generate synthetic positive controls possessing either SNP states.
Each allele-specific amplicon was generated by the use of an allele-
specific forward primer and a common reverse primer (IDT, San
Diego, CA). PCR cycled at 94uC for 30 sec, 58uC for 30 sec, 72uC
for 30 sec, with a final extension at 72uC for 5 min (total of 35 times).
All reagents and other PCR conditions were identical to those cited
in the Agarose MAMA methods. These final PCR amplicons,
possessing the ancestral and derived SNP-states, were used as
positive control templates for their specific assay at 1/100,000
dilution.
Supporting Information
Figure S1 Design principle of the allele-specific syn-
thetic positive control. This figure shows the construction of
allele-specific amplicons (A & B). The SNP allele state of the
amplicon is encoded by the base identity of the 39 end of the allele-
specific (AS) forward primer in the PCR (Ai–iii & Bi–iii). The
annealing of AS- primers to their allelic (matched) template (Ai)
and non-allelic (non-matched) template (Bi) is shown. (Aii & Bii)
Taq Polymerase extends from the 39 end of the AS-MAMA primer
on both allelic and non-allelic templates. The single 39-end
mismatch does not significantly hinder the Taq Polymerase-
mediated extension on the non-allelic template (Bii). The newly
synthesized DNA made in the previous PCR step (Aii & Bii) serves
as the template for amplicon replication in the second PCR cycle
(Aiii & Biii). This results in the formation of a perfect primer-
template complex on the non-allelic template PCR (Biii). Maximal
PCR efficiency is achieved for both allele-specific amplicon types
(Aiv & Biv). Each amplicon is designed to be of ,150–200 bp
length.
(DOCX)
Table S1 Primer sequences and PCR conditions for
Melt-MAMAs. Primer sequences for synthetic positive controls
are provided for a subset of assays.
(XLSX)
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